Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.
Status:
Not yet recruiting
Trial end date:
2024-02-06
Target enrollment:
Participant gender:
Summary
Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in
Paediatric Patients with Myotonic Disorders Who Have Completed the MEX-NM-301 study.